PepGen (PEPG) Depreciation and Depletion (2021 - 2026)
PepGen (PEPG) reported Depreciation and Depletion of $319000.0 for Q1 2026, down 17.78% on a YoY basis from $388000.0 in Q1 2025, and down 5.06% sequentially from $336000.0 in Q4 2025.
PepGen (PEPG) Depreciation and Depletion (2021 - 2026) Analysis & Trends
PepGen (PEPG) has 6 years of Depreciation and Depletion data on file, last reported at $319000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation and Depletion fell 17.78% year-over-year to $319000.0; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (down 12.46% YoY), and the FY2025 full-year result was $1.4 million, down 7.18% from the prior year.
- Depreciation and Depletion retreated to $319000.0 in Q1 2026, from $336000.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $388000.0 in Q1 2025 to a low of $66000.0 in Q1 2022.
- A 5-year average of $288117.6 and a median of $336000.0 in 2025 frame the typical range for Depreciation and Depletion.
- Across the five-year window, Depreciation and Depletion soared 210.87% in 2022 and fell 17.78% in 2026, its largest moves.
- Tracing PEPG's Depreciation and Depletion over 5 years: stood at $145000.0 in 2022, then soared by 144.14% to $354000.0 in 2023, then increased by 7.34% to $380000.0 in 2024, then dropped by 11.58% to $336000.0 in 2025, then dropped by 5.06% to $319000.0 in 2026.
- Business Quant data shows PEPG's Depreciation and Depletion at $319000.0 in Q1 2026, $336000.0 in Q4 2025, and $339000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | PepGen | 145.09 Mn | 145.09 Mn | - | 319,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 319,000.00 |
| Mar 31, 2026 | 319,000.00 |
| Dec 31, 2025 | 336,000.00 |
| Dec 31, 2025 | 336,000.00 |
| Sep 30, 2025 | 339,000.00 |
| Sep 30, 2025 | 339,000.00 |
| Jun 30, 2025 | 334,000.00 |
| Jun 30, 2025 | 334,000.00 |
| Mar 31, 2025 | 388,000.00 |
| Mar 31, 2025 | 388,000.00 |
| Dec 31, 2024 | 380,000.00 |
| Dec 31, 2024 | 380,000.00 |
| Sep 30, 2024 | 379,000.00 |
| Sep 30, 2024 | 379,000.00 |
| Jun 30, 2024 | 370,000.00 |
| Jun 30, 2024 | 370,000.00 |
| Mar 31, 2024 | 376,000.00 |
| Mar 31, 2024 | 376,000.00 |
| Dec 31, 2023 | 354,000.00 |
| Dec 31, 2023 | 354,000.00 |